Bone marrow-derived NCS-01 cells for ischemic stroke
Bone marrow-derived NCS-01 cells for ischemic stroke
About this item
Full title
Author / Creator
Publisher
Mumbai: Wolters Kluwer India Pvt. Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Mumbai: Wolters Kluwer India Pvt. Ltd
Subjects
More information
Scope and Contents
Contents
Stroke stands as one of the most common causes of death among adults worldwide. Currently, tissue plasminogen activator serves as the only approved drug by the Food and Drug Administration for the treatment of acute ischemic stroke. Stem cell therapy serves as a viable treatment option and has been deemed as a safe and effective treatment for strok...
Alternative Titles
Full title
Bone marrow-derived NCS-01 cells for ischemic stroke
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_4b3f5202d6cd44e08638f1ff03675642
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4b3f5202d6cd44e08638f1ff03675642
Other Identifiers
ISSN
2394-8108,2455-4626
E-ISSN
2455-4626
DOI
10.4103/bc.bc_23_21
